Park National Corp OH Raises Position in HCA Healthcare, Inc. $HCA

Park National Corp OH grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 54.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,851 shares of the company’s stock after buying an additional 6,276 shares during the period. Park National Corp OH’s holdings in HCA Healthcare were worth $7,618,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of HCA Healthcare during the second quarter worth $5,069,974,000. Capital World Investors boosted its stake in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after acquiring an additional 40,086 shares during the period. Wellington Management Group LLP lifted its holdings in shares of HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after purchasing an additional 799,761 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of HCA Healthcare by 5.8% during the fourth quarter. Barclays PLC now owns 1,322,211 shares of the company’s stock valued at $617,287,000 after acquiring an additional 72,219 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $7.63 during midday trading on Monday, hitting $434.32. 365,073 shares of the stock were exchanged, compared to its average volume of 1,346,918. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The business’s fifty day simple moving average is $417.13 and its two-hundred day simple moving average is $421.56. The company has a market capitalization of $94.03 billion, a PE ratio of 14.54, a P/E/G ratio of 1.44 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the previous year, the company earned $6.84 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on HCA. BMO Capital Markets initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price objective on the stock. Barclays cut their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Robert W. Baird decreased their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Mizuho reduced their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a research note on Tuesday, September 8th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $463.70.

About HCA Healthcare

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.